HOME Top Market Reports Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018

Immunoassay Market [Technology (Enzyme, Fluorescent, Chemiluminescence, Radioimmunoassay), Analyzers & Reagents, Applications (Infectious Diseases, Cancer, Endocrinology, Cardiology), End Users (Hospitals, Laboratory, Academics)] – Global Forecast to 2018

By: marketsandmarkets.com
Publishing Date: October 2013
Report Code: BT 1653

Discount on Reports  

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The immunoassay instruments and reagents had witnessed a tremendous change and significant innovation since their evolution in the early nineties. The global market is valued at about $13.0 billion in 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $19.1 billion by 2018.

The expanding use of immunoassays, increasing demand for high quality healthcare services, and rapidly increasing geriatric population are the major factors that drives the global market. New and innovative product launches by key industry players also boosts the growth momentum of the market. Nevertheless, the rising commoditization of certain immunoassays, uncertain regulatory environment, and reduction in the healthcare budget are critical restraints for the market growth.

This research report categorizes the global market on the basis of technology, applications, products (analyzers and reagents), and end-users. On the basis of technology, the enzyme immunoassays segment accounted for the largest share of 35.2% of the global market in 2012.

The Americas and Europe are the established markets for immunoassays. The developing regions that include the BRIC countries (Brazil, Russia, India, and China) are expected to form the new revenue pockets for this market. The demand for sophisticated and non-invasive diagnostic techniques and increasing acceptance of personalized medicines are the emerging fields that attract the companies to plunge into the market.

The chemiluminescence immunoassays market is estimated to witness tremendous growth in the next five years as this market comprises of automated systems that offer the highest sensitivity. In addition, infectious diseases, endocrinology, oncology, and bone and mineral segments of the market are projected to witness high growth rates.

The usage of lateral flow immunoassay-based point-of-care (POC) tests has been on the rise to diagnose various diseases such as oncology, cardiology, and diabetes, and conditions such as pregnancy. In addition, biomarkers are also facing emerging trends in the market that uncovers new growth opportunities for immunoassay companies.

The global market is consolidated with the top seven market players together accounting for a market share of more than 85% in 2013. Roche is the market leader holding 21% of the market share in 2013.

Agreements, partnerships, collaborations, and joint ventures along with new product launches are the two most preferred strategies followed by the key players. Major strategic developments take place in the field of infectious disease immunoassay tests that run on automated platforms, which exhibits high-growth potential in the near future. In addition, companies such as Abbott, focuses on receiving various regional approvals to gain an edge in the competition. Companies such as Danaher Corporation, QIAGEN N.V., and Thermo Fisher Scientific Inc. adopted mergers and acquisitions as their dominant strategy to keep up with the pace of the industry.

Dominant market players such as Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, and Abbott Laboratories Inc. introduced several tests to diagnose infectious diseases in order to sustain their growth in the market.

The demand for sophisticated and non-invasive diagnostic techniques and the increasing acceptance of personalized medicines are the emerging fields that attract the companies to plunge into the market.

Table Of Contents
 
1 Introduction (Page No. - 30)
  1.1 Key Take-Aways
  1.2 Report Description
  1.3 Research Methodology
      1.3.1 Secondary Sources
      1.3.2 Primary Sources
      1.3.3 Market Size Estimation
      1.3.4 Market Share
      1.3.5 Key Data Points From Secondary Sources
      1.3.6 Key Data Points From Primary Sources
      1.3.7 Assumptions
  1.4 Markets Covered
  1.5 Stakeholders
  1.6 Market Scope

2 Executive Summary (Page No. - 45)

3 Premium Insights (Page No. - 48)
  3.1 Immunoassay Market Vs Other IVD Market Segments
  3.2 Geographic Analysis, By Country
  3.3 Applications Market
  3.4 End-User Analysis
  3.5 Competitive Analysis

4 Industry Analysis & Market Overview (Page No. - 54)
  4.1 Introduction
  4.2 Evolution
  4.3 Market Segmentation
  4.4 Market Dynamics
      4.4.1 Drivers
            4.4.1.1 Rising Incidence Of Chronic And Infectious Diseases In Emerging Economies To Drive The Immunoassay Market
            4.4.1.2 Rapidly Aging Population Will Result In Increasing Chronic Diseases
            4.4.1.3 Growing Popularity Of Portable Immunoassay To Stimulate Growth
            4.4.1.4 Novel Biomarkers And Innovative Technologies To Give An Edge To Immunoassay Companies
            4.4.1.5 Sensitive, Cost-Effective, & Rapidness Of Immunoassay Increases Adoption Rates
            4.4.1.6 Increasing Health Awareness Responsible For The Growth Of The Immunoassay Market
      4.4.2 Restraints
            4.4.2.1 Low Detection Limits Restrict Adoption Of Immunoassay Tests
            4.4.2.2 Lack Of Budget To Restrict Growth
      4.4.3 Opportunities
            4.4.3.1 New Range Of Condition-Specific Markers And Tests With Advances In Genomics And Proteomics
            4.4.3.2 Increasing Adoption In Emerging Markets Such As China And India Are Creating Growth Opportunities For The Immunoassay Market
      4.4.4 Threats
            4.4.4.1 Pricing Pressure For Some Tests Due To Competition From Lower Cost-Per-Test Technologies
            4.4.4.2 Stringent Regulatory Framework Acts As A Major Challenge
  4.5 Burning Issues
      4.5.1 Lateral Flow Immunoassay
            4.5.1.1 Demand For LF Tests On The Rise
      4.5.2 Laboratory Automation For Increased Efficiency And Accurate Diagnosis
  4.6 Techniques To Validate New Biomarkers Using Immunoassay
  4.7 Regulations
      4.7.1 U.S.
      4.7.2 Europe
      4.7.3 Japan
      4.7.4 China
      4.7.5 India
  4.8 Reimbursement Scenario & Challenges
  4.9 Value Chain Analysis
  4.10 Porter’s Analysis
       4.10.1 Threat From New Entrants
       4.10.2 Threat From Substitutes
       4.10.3 Bargaining Power Of Buyers
       4.10.4 Bargaining Power Of Suppliers
       4.10.5 Competitive Rivalry Among Existing Players
  4.11 Pestel Analysis
       4.11.1 Political
       4.11.2 Economic
       4.11.3 Socio-Cultural
       4.11.4 Technological
       4.11.5 Environmental
       4.11.6 Legal
  4.12 Market Share Analysis
       4.12.1 Global
       4.12.2 Americas
       4.12.3 Europe
       4.12.4 Asia-Pacific

5 Immunoassay Market, By Technology (Page No. - 86)
  5.1 Introduction
  5.2 Enzyme Immunoassay (EIA)
      5.2.1 EIA Is The Most Preferred Technique In The Immunoassay Market
  5.3 Fluorescence Immunoassay (FIA)
      5.3.1 Sensitivity Along With Low Cost Of FIA Drives The Market
  5.4 Chemiluminescence Immunoassay (CLIA)
      5.4.1 High Sensitivity, Automation & Wide Applications Of CLIA Responsible For The Highest Growth
  5.5 Radioimmunoassays (RIA)
      5.5.1 Despite Wide Applications & High Sensitivity, RIA To Lose Share To Safer Technologies Like EIA & CLIA
  5.6 Others [Nephelometry, Turbidimetry, & Counting Immunoassay (CIA)]
      5.6.1 Nephelometry Will Grow At A Meager Pace Due To Lack Of Major Advancements
      5.6.2 Turbidometry & CIA To Grow At A Decent Rate
  5.7 The Immunoassay Market Vs. Other IVD Segments
      5.7.1 Immunoassay Contribute The Highest To IVD Market; Molecular Diagnostics Segment Will Grow The Fastest

6 Immunoassay Market, By Products (Analyzers & Reagents) (Page No. - 118)
  6.1 Introduction
      6.1.1 Reagents Market To Grow With Increase In Test Volumes
  6.2 Analyzers
      6.2.1 Medium-Throughput Analyzers Contribute The Highest To The Analyzers Revenue
      6.2.2 High-Throughput Analyzers
            6.2.2.1 High Throughput Analyzers Will Witness The Fastest Growth
      6.2.3 Medium-Throughput Analyzers
      6.2.4 Low-Throughput Analyzers
  6.3 Reagents
      6.3.1 Home Brew Assays Are Subject To Lenient Regulations

7 Immunoassay Market, By Application (Page No. - 132)
  7.1 Introduction
  7.2 Oncology
      7.2.1 Oncology Biomarkers Can Help Early Detection Of Cancers
  7.3 Endocrinology
      7.3.1 Endocrinology Segment Will Be Driven By Increasing Incidences Of Diabetes & Thyroid Disorders
  7.4 Bone & Mineral
      7.4.1 Increasing Prevalence Of Bone & Mineral Disorders To Propel The Immunoassay Market
  7.5 Cardiology
      7.5.1 Immunoassay Techniques Are Frequently Used For Diagnosis Of Cardiac Ailments
      7.5.2 Troponin Is The Most Preferred Biomarker In Cardiology
  7.6 Infectious Diseases
      7.6.1 Increasing Investments In The Infectious Diseases Due To High-Share, High-Growth Rate Nature Of The Segment
  7.7 Hematology
  7.8 Autoimmunity
      7.8.1 Autoimmunity Segment Provides Significant Growth Opportunities To Immunoassay Players
  7.9 Toxicology
      7.9.1 Increasing Drug-Abuse Cases To Boost Immunoassay Toxicology Market
  7.10 Neonatal Screening
       7.10.1 Novel Biomarkers Identified For Newborn Screening In Public Health Practices
  7.11 Others (Allergy, Stool Testing, & Serology)

8 Global Immunoassay Market, By End-Users (Page No. - 161)
  8.1 Introduction
  8.2 Hospitals (Private/Public)
      8.2.1 Hospitals As End-Users Is A High Growth Rate, High Market Size Segment
  8.3 Laboratories (Private/Public)
      8.3.1 Laboratories Offer Various Advantages Over Hospitals Yet Will Grow At Lower Rate Due To Smaller Volumes
  8.4 Academics
  8.5 Pharmaceutical Industry, Cros, & Biotechs
      8.5.1 Increasing Research Activities To Drive The Industrial Segment
  8.6 Others (Physicians’ Offices, Blood Banks, Patient Self-Testing, & Ambulatory Centers)
      8.6.1 The Demand For PST Is On A Rise

9 Geographic Analysis (Page No. - 169)
  9.1 Introduction
      9.1.1 U.S. The Major Contributor To Immunoassay Owing To Technological Advancements & Government Support
      9.1.2 Asian And Latam Countries Offer Huge Opportunities To Investors
  9.2 The Americas
      9.2.1 U.S.
            9.2.1.1 PPACA Has A Positive Impact On Immunoassay Business
            9.2.1.2 Despite Unfavorable Conditions Key Players Look To Consolidate Their Business In U.S.
      9.2.2 Canada
            9.2.3 Mexico
                  9.2.3.1 Government Regulations & Reforms Support The Growth Of Immunoassay In Mexico
            9.2.4 Brazil
                  9.2.4.1 Healthcare Reforms, Government Initiatives & Rise Of Infectious Diseases To Drive The Brazilian Immunoassay Market
            9.2.5 Rest Of Americas (ROA)
  9.3 Europe
      9.3.1 Europe Immunoassay Market Will Grow At A Slow Pace Due To Decreased Funding & Strict Regulatory Guidelines
      9.3.2 Germany
            9.3.2.1 Germany To Grow At A High Pace Due To Presence Of Defined Outsourcing Chain Of Laboratory Services & Government Support
      9.3.3 France
            9.3.3.1 France Is The Second Biggest Immunoassay Market In Europe
      9.3.4 Italy
            9.3.4.1 Italy Will Grow At A Decent Pace Despite Various Challenges
      9.3.5 Spain
            9.3.5.1 Spain To Grow At A Meager Pace Due To Budget Cuts And Late Payments
      9.3.6 U.K.
            9.3.6.1 U.K.To Grow At The Fastest Rate In Europe Despite Roadblocks
      9.3.7 Rest Of Europe (ROE)
  9.4 Asia-Pacific
      9.4.1 Japan
            9.4.1.1 Japanese Immunoassay Market To Grow The Slowest In Asia Due To Regulatory Issues & Diagnostic Lag
      9.4.2 India
            9.4.2.1 Large Population Base, Increased Affordability & Government Initiatives Drive The Indian Immunoassay Market
      9.4.3 China
            9.4.3.1 China Will Be The Fastest Growing Immunoassay Market, Globally
      9.4.4 South Korea
            9.4.4.1 South Korea To Witness Double-Digit Growth In The Immunoassay Arena
      9.4.5 Taiwan
            9.4.5.1 Taiwan To Grow At Brisk Pace In The Immunoassay Business
      9.4.6 ROAP
  9.5 Rest Of The World (ROW)
 
10 Competitive Landscape (Page No. - 262)
  10.1 Introduction
       10.1.1 Agreements, Partnerships & JVS Is The Key Growth Strategy Adopted By Players
  10.2 Agreements, Partnerships, Collaborations, & Joint Ventures
  10.3 New Product Launches
  10.4 Mergers & Acquisitions
  10.5 Other Developments

11 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments) * (Page No. - 270)
   11.1 Abbott Laboratories, Inc.
   11.2 Alere, Inc.
   11.3 Becton, Dickinson And Company
   11.4 Biomιrieux
   11.5 Danaher Corporation (Beckman Coulter)
   11.6 Diasorin S.P.A
   11.7 Diasource Immunoassays S.A.
   11.8 DRG International, Inc.
   11.9 Hologic (Gen-Probe )
   11.10 IBL International GMBH
   11.11 IDS Plc
   11.12 Meridian Life Science, Inc.
   11.13 Ortho Clinical Diagnostics (A J&J Company)
   11.14 Qiagen N.V.
   11.15 Roche Diagnostics Limited
   11.16 Siemens Healthcare
   11.17 Sysmex Corporation
   11.18 Thermo Fisher Scientific, Inc. (Brahms)
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.

12 Appendix (Page No. - 396)


List Of Tables (118 Tables)
 
Table 1 Global Market, By Technology, 2011 – 2018 ($Million)
Table 2 Enzyme Immunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 3 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 4 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 5 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 6 Fluorescent Immunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 7 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 8 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 9 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 10 Chemiluminescence Immunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 11 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 12 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 13 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 14 Radioimmunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 15 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 16 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 17 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 18 Other Immunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 19 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 20 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 21 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 22 Global In Vitro Diagnostics Market, By Technique, 2011 – 2018 ($Million)
Table 23 Global Market, By Product, 2011 – 2018 ($Million)
Table 24 Global Market, By Throughput, 2011 – 2018 ($Million)
Table 25 Immunoassay Analyzers Market, By Geography, 2011 – 2018 ($Million)
Table 26 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 27 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 28 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 29 Immunoassay Reagents Market, By Geography, 2011 – 2018 ($Million)
Table 30 Americas: Market, By Country, 2011 – 2018 ($Million)
Table 31 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 32 Asia-Pacific: Market, By Country, 2011 – 2018 ($Million)
Table 33 Global Immunoassay Market, By Application, 2011 – 2018 ($Million)
Table 34 Oncology Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 35 Endocrinology Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 36 Bone & Mineral Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 37 Commonly Used Cardiac Biomarker Tests
Table 38 Cardiac Biomarker Tests Used For Prognosis
Table 39 Cardiology Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 40 Infectious Diseases Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 41 Hematology Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 42 Autoimmunity Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 43 Toxicology Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 44 Neonatal Screening Immunoassays Market, By Geography, 2011 – 2018 ($Million)
Table 45 Other Immunoassay Applications Market, By Geography, 2011 – 2018 ($Million)
Table 46 Global Immunoassay Market, By End-Users, 2011 – 2018 ($Million)
Table 47 Immunoassay Market, By Geography, 2011 – 2018 ($Million)
Table 48 The Americas: Immunoassay Market, By Country, 2011 – 2018 ($Million)
Table 49 The Americas: Market, By Technology, 2011 – 2018 ($Million)
Table 50 Americas: Market, By Product, 2011 – 2018 ($Million)
Table 51 Americas: Market, By Application, 2011 – 2018 ($Million)
Table 52 U.S.: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 53 U.S.: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 54 U.S.: Market, By Application, 2011 – 2018 ($Million)
Table 55 Canada: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 56 Canada: Market, By Product, 2011 – 2018 ($Million)
Table 57 Canada: Market, By Application, 2011 – 2018 ($Million)
Table 58 Mexico: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 59 Mexico: Market, By Product, 2011 – 2018 ($Million)
Table 60 Mexico: Market, By Application, 2011 – 2018 ($Million)
Table 61 Brazil: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 62 Brazil: Market, By Product, 2011 – 2018 ($Million)
Table 63 Brazil: Market, By Application, 2011 – 2018 ($Million)
Table 64 ROA: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 65 ROA: Market, By Product, 2011 – 2018 ($Million)
Table 66 ROA: Market, By Application, 2011 – 2018 ($Million)
Table 67 Europe: Market, By Country, 2011 – 2018 ($Million)
Table 68 Europe: Market, By Technology, 2011 – 2018 ($Million)
Table 69 Europe: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 70 Europe: Immunoassay Market, By Application, 2011 – 2018 ($Million)
Table 71 Germany:Market, By Technology, 2011 – 2018 ($Million)
Table 72 Germany: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 73 Germany: Market, By Application, 2011 – 2018 ($Million)
Table 74 France: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 75 France: Market, By Product, 2011 – 2018 ($Million)
Table 76 France: Market, By Application, 2011 – 2018 ($Million)
Table 77 Italy: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 78 Italy: Market, By Product, 2011 – 2018 ($Million)
Table 79 Italy: Market, By Application, 2011 – 2018 ($Million)
Table 80 Spain: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 81 Spain: Market, By Product, 2011 – 2018 ($Million)
Table 82 Spain: Market, By Application, 2011 – 2018 ($Million)
Table 83 U.K.: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 84 U.K.: Market, By Product, 2011 – 2018 ($Million)
Table 85 U.K.: Market, By Application, 2011 – 2018 ($Million)
Table 86 ROE: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 87 ROE: Market, By Product, 2011 – 2018 ($Million)
Table 88 ROE: Market, By Application, 2011 – 2018 ($Million)
Table 89 Asia-Pacific: Immunoassay Market, By Country, 2011 – 2018 ($Million)
Table 90 Asia-Pacific: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 91 Asia-Pacific: Market, By Product, 2011 – 2018 ($Million)
Table 92 Asia-Pacific: Market, By Application, 2011 – 2018 ($Million)
Table 93 Japan: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 94 Japan: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 95 Japan: Market, By Application, 2011 – 2018 ($Million)
Table 96 India: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 97 India: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 98 India: Market, By Application, 2011 – 2018 ($Million)
Table 99 China: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 100 China: Market, By Product, 2011 – 2018 ($Million)
Table 101 China: Immunoassays Market, By Application, 2011 – 2018 ($Million)
Table 102 South Korea: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 103 South Korea: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 104 South Korea: Market, By Application, 2011 – 2018 ($Million)
Table 105 Taiwan: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 106 Taiwan: Market, By Product, 2011 – 2018 ($Million)
Table 107 Taiwan: Market, By Application, 2011 – 2018 ($Million)
Table 108 ROAP: Immunoassay arket, By Technology, 2011 – 2018 ($Million)
Table 109 ROAP: Market, By Product, 2011 – 2018 ($Million)
Table 110 ROAP: Market, By Application, 2011 – 2018 ($Million)
Table 111 ROW: Immunoassay Market, By Technology, 2011 – 2018 ($Million)
Table 112 ROW: Immunoassay Market, By Product, 2011 – 2018 ($Million)
Table 113 ROW: Market, By Application, 2011 – 2018 ($Million)
Table 114 Agreements, Partnerships, Collaborations, & Joint Ventures (2010 – 2013)
Table 115 New Product Launches (2010 – 2013)
Table 116 Mergers & Acquisitions (2010 – 2013)
Table 117 Other Developments (2011 – 2013)
Table 118 Appendix: Other Developments (2010 – 2013)
 
 
List Of Figures (86 Figures)

 
Figure 1 Research Methodology For The Immunoassays Market
Figure 2 Market Size Estimation Methodology For The Immunoassays Market
Figure 3 Forecast Model
Figure 4 Data Triangulation Methodology (360o Evaluation)
Figure 5 Global Immunoassays Market, By Technology, 2013 – 2018 ($Million)
Figure 6 Comparison Of Immunoassay & Other IVD Segments (2013)
Figure 7 Immunoassay Market: Geographic Analysis, 2013 ($Million)
Figure 8 Immunoassay Market: By Applications, 2011 – 2018 (Market Size & Growth Rates)
Figure 9 Immunoassay Market: By Applications, 2013
Figure 10 Immunoassay Market: End-User Analysis, 2013 Vs 2018
Figure 11 Immunoassay Market Key Players: Geographic Reach Vs Product Portfolio (2013)
Figure 12 Immunoassay Market Evolution
Figure 13 Immunoassay Market Segmentation
Figure 14 Immunoassay Market Dynamics
Figure 15 Approval Process Flowchart
Figure 16 Immunoassay Market: Value Chain Analysis For Instruments
Figure 17 Porter’s Five Forces Analysis: Immunoassay Market
Figure 18 Pestel Analysis: Immunoassay Market
Figure 19 Global Immunoassay Market Share Analysis, By Key Players, 2012
Figure 20 Americas: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 21 Europe: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 22 Asia-Pacific: Immunoassay Market Share Analysis, By Key Players, 2012
Figure 23 Global In Vitro Diagnostics Market, By Technique, 2013 ($Million)
Figure 24 Global Immunoassay Market, By Application, 2013 – 2018
Figure 25 Global Immunoassay Market, End-User Positioning
Figure 26 Global Immunoassay Market, By End-Users, 2013 – 2018
Figure 27 Immunoassay Market: Geographic Phases, 2013
Figure 28 Opportunity Matrix: Immunoassay Market, By Country, 2013 – 2018 ($Million)
Figure 29 Key Growth Strategy, 2010 – 2013
Figure 30 Abbott Laboratories, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 31 Abbott Laboratories, Inc.: Business Revenue Mix, 2012
Figure 32 Abbott Laboratories, Inc.: Geographic Revenue Mix, 2012
Figure 33 Abbott Laboratories, Inc.: Market Strategy, 2011 – 2013
Figure 34 Alere, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 35 Alere, Inc.: Business Revenue Mix, 2012
Figure 36 Alere, Inc.: Geographic Revenue Mix, 2012
Figure 37 Alere, Inc. Market Strategy, 2011 – 2013
Figure 38 Becton, Dickinson And Company: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 39 Becton, Dickinson And Company: Business Revenue Mix, 2012
Figure 40 Becton, Dickinson And Company: Geographic Revenue Mix, 2012
Figure 41 Becton, Dickinson And Company: Market Strategy, 2011 – 2013
Figure 42 Biomιrieux: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 43 Biomιrieux: Business Revenue Mix, 2012
Figure 44 Biomιrieux: Geographic Revenue Mix, 2012
Figure 45 Biomιrieux: Market Strategy, 2011 – 2013
Figure 46 Danaher Corporation: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 47 Danaher Corporation: Business Revenue Mix, 2012
Figure 48 Danaher Corporation: Geographic Revenue Mix, 2012
Figure 49 Danaher Corporation: Market Strategy, 2011 – 2013
Figure 50 Diasorin S.P.A.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 51 Diasorin S.P.A.: Business Revenue Mix, 2012
Figure 52 Diasorin S.P.A.: Geographic Revenue Mix, 2012
Figure 53 Diasorin S.P.A.: Market Strategy, 2011 – 2013
Figure 54 Hologic, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 55 Hologic, Inc.: Business Revenue Mix, 2012
Figure 56 Hologic, Inc.: Geographic Revenue Mix, 2011
Figure 57 Hologic, Inc.: Market Strategy, 2011 – 2013
Figure 58 IDS PLC.: Total Revenue, 2011 – 2013
Figure 59 IDS PLC.: Business Revenue Mix, 2013
Figure 60 IDS PLC.: Geographic Revenue Mix, 2013
Figure 61 Meridian Bioscience, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 62 Meridian Bioscience, Inc.: Business Revenue Mix, 2012
Figure 63 Johnson & Johnson: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 64 Johnson & Johnson: Business Revenue Mix, 2012
Figure 65 Johnson & Johnson: Geographic Revenue Mix, 2012
Figure 66 Johnson & Johnson: Market Strategy, 2011 – 2013
Figure 67 Qiagen N.V.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 68 Qiagen N.V.: Business Revenue Mix, 2012
Figure 69 Qiagen N.V.: Geographic Revenue Mix, 2012
Figure 70 Qiagen N.V.: Market Strategy, 2011 – 2013
Figure 71 Roche Diagnostics: Total Diagnostics Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 72 Roche Diagnostics: Business Revenue Mix (Diagnostics Division), 2012
Figure 73 Roche Diagnostics: Geographic Revenue Mix (Diagnostics Division), 2012
Figure 74 Roche Diagnostics: Market Strategy, 2011 – 2013
Figure 75 Siemens Healthcare: Total Revenue, 2010 – 2012
Figure 76 Siemens Healthcare: Business Revenue Mix, 2012
Figure 77 Siemens Healthcare: Geographic Revenue Mix, 2012
Figure 78 Siemens Healthcare: Market Strategy, 2011 – 2013
Figure 79 Sysmex Corporation: Total Revenue ($Million), 2011 – 2013
Figure 80 Sysmex Corporation: Business Revenue Mix, 2013
Figure 81 Sysmex Corporation: Geographic Revenue Mix, 2013
Figure 82 Sysmex Corporation: Market Strategy, 2011 – 2013
Figure 83 Thermo Fisher Scientific, Inc.: Total Revenue ($Million) & Operating Margin (%), 2010 – 2012
Figure 84 Thermo Fisher Scientific, Inc.: Business Revenue Mix, 2012
Figure 85 Thermo Fisher Scientific, Inc.: Geographic Revenue Mix, 2012
Figure 86 Thermo Fisher Scientific, Inc.: Market Strategy, 2011 – 2013
 
 
 

The global market is segmented on the basis of technology, application, product (analyzers and reagents), and end user. The global market, by technology, is further segmented into enzyme, fluorescent, chemiluminescence immunoassay, radioimmunoassay, and others. Enzyme and chemiluminescence immunoassay are two of the largest segments, accounting for a total of ~65% of the market share globally in 2012.

By application, this market has segments like oncology, infectious diseases, cardiology, bone and mineral, endocrinology, autoimmunity, toxicology, hematology, neonatal screening, and others. Infectious disease is the largest segment with more than one-third share of the total market. This is attributed to the increasing prevalence of infectious diseases along with continuous product innovations and launches.

The global market is valued around $13.0 billion in 2013 and is expected to grow at a healthy CAGR of 8.1% to reach $19.1 billion by 2018. Expanding use of immunoassay, increasing demand for high-quality healthcare services, and rapidly increasing geriatric population are the major factors driving the global market. New and innovative product launches by the key industry players also boost the market. However, the rising commoditization of certain immunoassay, uncertain regulatory environment, and reduction in the healthcare budget are critical restraints for the growth of the market.

The key market vendors in this arena are Abbott Laboratories (U.S.), Alere, Inc. (U.S.), Danaher Corporation (U.S.), DiaSorin S.P.A. (Italy), Ortho Clinical Diagnostics (U.S.), Roche Diagnostics (Switzerland), Siemens Healthcare (Germany), and Sysmex Corporation (Japan).

GLOBAL IMMUNOASSAY MARKET SCENARIO

Immunoassay Market

Source: Annual Reports, SEC Filings, Expert Interviews, and MarketsandMarkets Analysis

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports